Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
Aparicio, Jorge, Virgili Manrique, Anna C., Capdevila, Jaume, Muñoz Boza, Félix, Galván, Patricia, Richart, Paula, Oliveres, Helena, Páez, David, Hernando, Jorge, Serrano, Sara, Vera, Ruth, Hernandez-Yagüe, Xavier, Gallego, Rafael Álvarez, Riesco-Martinez, M. Carmen, García de Albeniz, Xavier, Maurel, Joan
Published in Clinical & translational oncology (01.11.2022)
Published in Clinical & translational oncology (01.11.2022)
Get full text
Journal Article